Yaqing Shu

Dr. Yaqing Shu


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2023 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
YSYaqing Shu
Yaqing Shu
FPFuhua Peng
Fuhua Peng
BZBingchu Zhao
Bingchu Zhao
CLchunxin liu
chunxin liu
QLQihui Li
Qihui Li
WQWei Qiu
Wei Qiu
Background: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a severe autoimmune neuropsychiatric disease. Brain access of anti-NMDAR autoantibody through the blood–brain barrier (BBB) is essential for pathogenesis. Most previous animal models limit the investigation of etiologies of BBB damage in patients. Methods: In this study, we established a novel humanized mouse model of anti-NMDAR encephalitis by intraperitoneal injection of patients’ peripheral blood mononuclear cells (PBMCs) into BALB/c Rag2−/−Il2rg−/−SirpαNODFlk2−/− mice. Results: We found that engraftment of patients’ PBMCs not only produced potent anti-GluN1 autoantibodies, but also disrupted BBB integrity to allow brain access of autoantibodies, resulting in a hyperactive locomotor phenotype, anxiety- and depressive-like behaviors, cognitive deficits, as well as functional changes in corresponding brain regions. Transcriptome analysis suggested an exaggerated immune response and impaired neurotransmission in the mouse model and highlighted Il-1β as a hub gene implicated in pathological changes. We further demonstrated that Il-1β was produced by endothelial cells and disrupted BBB by repressing tight junction proteins. Treatment with Anakinra, an Il-1 receptor antagonist, ameliorated BBB damage and neuropsychiatric behaviors. Conclusions: Our study provided a novel and clinically more relevant humanized mouse model of anti-NMDAR encephalitis and revealed an intrinsic pathogenic property of the patient’s lymphocytes.

14 August 2024 in Environment International
Verified
Journal Article
Open access
JLJiehao Li
Jiehao Li
LZLixin Zhou
Lixin Zhou
SHSongyi Huang
Songyi Huang
TDTiantian Duan
Tiantian Duan
JXJinying Xie
Jinying Xie
Pan YangPan Yang
Pan Yang
Endocrine-disrupting chemicals (EDCs) exhibited the detriment in female reproductive health. Our objective was to investigate the individual and mixture effects of EDCs present in follicular fluid, the environment in which oocytes grow and develop, on early reproductive outcomes. We recruited 188 women seeking reproduction examination from the Study of Exposure and Reproductive Health (SEARCH) cohort between December 2020 and November 2021. We assessed the concentrations of 7 categories of 64 EDCs in follicular fluid, and measured early reproductive outcomes, including retrieved oocytes, mature oocytes, normal fertilized oocytes, and high-quality embryos. In this study Monomethyl phthalate (MMP) (2.17 ng/ml) were the compounds found in the highest median concentrations in follicular fluid. After adjusting for multiple testing, multivariate regression showed that multiple EDCs were significantly negatively associated with early assisted reproduction outcomes. For example, MMP showed a significant negative correlation with the number of high quality embryos (β: -0.1, 95 % CI: -0.15, -0.04). Specifically, eight types of EDCs were significantly negatively associated with four early assisted reproductive outcomes (β range: -0.2 ∼ -0.03). In the mixed exposure model, we found that mixtures of EDC were significantly negatively correlated with all four outcomes. In the quantile g-computation (QGCOMP) model, for each interquartile range increase in the concentration of EDC mixtures, the number of oocytes retrieved, mature oocytes, normally fertilized oocytes, and high-quality embryos decreased by 0.46, 0.52, 0.77, and 1.2, respectively. Moreover, we identified that phthalates (PAEs) predominantly contributed to the negative effects. Future research should validate our findings.

1 May 2024 in Neurology Neuroimmunology & Neuroinflammation
Verified
Journal Article
Open access
XLXu Liu
Xu Liu
XZXiaodong Zheng
Xiaodong Zheng
YSYaqing Shu
Yaqing Shu
XQXiao Qu
Xiao Qu
QWQun Wang
Qun Wang
ZHZhen Hong
Zhen Hong
Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is a rare autoimmune neurologic disorder, the genetic etiology of which remains poorly understood. Our study aims to investigate the genetic basis of this disease in the Chinese Han population. We performed a genome-wide association study and fine-mapping study within the major histocompatibility complex (MHC) region of 413 Chinese patients with anti-NMDAR encephalitis recruited from 6 large tertiary hospitals and 7,127 healthy controls. Our genome-wide association analysis identified a strong association at the IFIH1 locus on chromosome 2q24.2 (rs3747517, p = 1.06 × 10-8, OR = 1.55, 95% CI, 1.34-1.80), outside of the human leukocyte antigen (HLA) region. Furthermore, through a fine-mapping study of the MHC region, we discovered associations for 3 specific HLA class I and II alleles. Notably, HLA-DQB1*05:02 (p = 1.43 × 10-12; OR, 2.10; 95% CI 1.70-2.59) demonstrates the strongest association among classical HLA alleles, closely followed by HLA-A*11:01 (p = 4.36 × 10-7; OR, 1.52; 95% CI 1.29-1.79) and HLA-A*02:07 (p = 1.28 × 10-8; OR, 1.87; 95% CI 1.50-2.31). In addition, we uncovered 2 main HLA amino acid variation associated with anti-NMDAR encephalitis including HLA-DQβ1-126H (p = 1.43 × 10-12; OR, 2.10; 95% CI 1.70-2.59), exhibiting a predisposing effect, and HLA-B-97R (p = 3.40 × 10-8; OR, 0.63; 95% CI 0.53-0.74), conferring a protective effect. Computational docking analysis suggested a close relationship between the NR1 subunit of NMDAR and DQB1*05:02. Our findings indicate that genetic variation in IFIH1, involved in the type I interferon signaling pathway and innate immunity, along with variations in the HLA class I and class II genes, has substantial implications for the susceptibility to anti-NMDAR encephalitis in the Chinese Han population.

18 January 2022 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
XMXiaoyu Ma
Xiaoyu Ma
YLYaxin Lu
Yaxin Lu
FPFuhua Peng
Fuhua Peng
YWYuge Wang
Yuge Wang
XSXiaobo Sun
Xiaobo Sun
YSYaqing Shu
Yaqing Shu

1 January 2022 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
XCXiaodong Chen
Xiaodong Chen
JZJing Zhou
Jing Zhou
RLRui Li
Rui Li
BZBingjun Zhang
Bingjun Zhang
YWYuge Wang
Yuge Wang
WQWei Qiu
Wei Qiu
Chen X, et al. J Clin Neurol. 2022 Jul;18(4):453-462. https://doi.org/10.3988/jcn.2022.18.4.453

28 July 2025 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
QLQihui Li
Qihui Li
LXLi Xiao
Li Xiao
JLJianfang Li
Jianfang Li
YHYu Huang
Yu Huang
SSShishi Shen
Shishi Shen
YSYaqing Shu
Yaqing Shu